Toggle navigation
Home
Search
Services
Blog
Contact
About
Bcr-Abl and Ras in Cml Evolution, Phenotype, Prognosis
Lebowitz, Paul
Yale University, New Haven, CT, United States
Search 3 grants from Paul Lebowitz
Search grants from Yale University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mechanism of Action of Antitumor Drugs
No &02-IN Postmyocardial Infarction Remodeling & Fa
Matrix Metalloproteinases-Subcapsular Cataract Formation
In Vivo Study of Interstitial Convection
Structure and Function of the MAC-1 Gene
Recently added grants:
Cell Therapy for Neuroprotection in Congenital Heart Disease
The Genetic and Molecular Basis of Cholesterol Efflux
Epigenomics of mononuclear phagocytes in prematurity associated lung disease
Mechanistic insights into HIV-mediated heart failure with preserved ejection fraction
Natural Killer Cell Functions in Lymphangioleiomyomatosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA049238-01
Application #
3193268
Study Section
Pathology B Study Section (PTHB)
Project Start
1989-01-09
Project End
1991-12-31
Budget Start
1989-01-09
Budget End
1989-12-31
Support Year
1
Fiscal Year
1989
Total Cost
Indirect Cost
Institution
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Related projects
NIH 1991
R01 CA
Bcr-Abl and Ras in Cml Evolution, Phenotype, Prognosis
Lebowitz, Paul / Yale University
NIH 1990
R01 CA
Bcr-Abl and Ras in Cml Evolution, Phenotype, Prognosis
Lebowitz, Paul / Yale University
NIH 1989
R01 CA
Bcr-Abl and Ras in Cml Evolution, Phenotype, Prognosis
Lebowitz, Paul / Yale University
Publications
Morris, S W; Daniel, L; Ahmed, C M et al.
(1990)
Relationship of bcr breakpoint to chronic phase duration, survival, and blast crisis lineage in chronic myelogenous leukemia patients presenting in early chronic phase.
Blood 75:2035-41
Comments
Be the first to comment on Paul Lebowitz's grant